Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis-Reference-Cited by-同舟云学术

Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis

Published:2021-08-11 Issue:4 Volume:28 Page:267-268
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Saith Sunil E.¹^ORCID,Gamino Danilo¹,Teruya Sergio¹,Guadalupe Samantha¹,Helmke Stephen¹,Santos Jeffeny De Los¹,Goldsmith Jeff¹,Rosenblum Hannah R.¹,Griffin Jan M.¹,Maurer Mathew S.¹^ORCID

Affiliation:

1. Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA

Funder

Amyloid Foundation USA

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2021.1904390

Reference5 articles.

1. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

2. Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy

3. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin

4. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis

5. Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No body fits in the test tube – the case of transthyretin;Amyloid;2024-09-08

2. Cardiac Amyloidosis Due to Transthyretin Protein;JAMA;2024-03-05

3. Overview of Current and Emerging Therapies for Amyloid Transthyretin Cardiomyopathy;The American Journal of Cardiology;2022-12

4. Tafamidis polyneuropathy amelioration requires modest increases in transthyretin stability even though increases in plasma native TTR and decreases in non-native TTR do not predict response;Amyloid;2022-09-30

5. Clinical Clues and Diagnostic Workup of Cardiac Amyloidosis;Methodist DeBakey Cardiovascular Journal;2022